World Hepatitis Day 2026: Hyderabad Urged to Step Up Fight Against Silent Killer Viral Hepatitis

Every year on July 28, World Hepatitis Day reminds the global community that viral hepatitis continues to be one of the leading causes of chronic liver disease and liver cancer.

This year’s theme, “Hepatitis: Let’s Break It Down,” calls upon governments, healthcare providers and communities to remove the barriers that prevent people from accessing timely diagnosis, vaccination and treatment. Despite remarkable advances in medicine, hepatitis remains a silent epidemic because millions continue to live with the infection without knowing it.

Hyderabad has emerged as one of India’s major healthcare hubs, attracting patients from across Telangana, Andhra Pradesh and neighbouring states for advanced liver care.

At the same time, rapid urbanisation, increasing lifestyle-related liver disorders and lack of awareness about viral hepatitis make early screening more important than ever. While sophisticated treatment options are available today, preventing liver damage begins with recognising the disease before symptoms appear.

Viral hepatitis refers to inflammation of the liver caused by viruses, primarily hepatitis A, B, C, D and E. Among these, hepatitis B and hepatitis C are the most concerning because they often remain silent for years before causing cirrhosis, liver failure or liver cancer. Many individuals discover the infection only after significant liver damage has already occurred.

One of the biggest challenges is that viral hepatitis rarely produces noticeable symptoms during its early stages. Fatigue, poor appetite, nausea or mild abdominal discomfort are often ignored. Jaundice, swelling of the abdomen or unexplained weight loss usually appear only when liver disease has progressed considerably. This is why hepatitis is often called a “silent killer.”

The encouraging news is that viral hepatitis is both preventable and, in many cases, treatable. Hepatitis B can be effectively prevented through vaccination, while hepatitis C can now be cured in the vast majority of patients with modern antiviral medications. Early diagnosis significantly reduces the risk of complications and improves long-term survival.

Vaccination remains one of the strongest weapons against hepatitis B. Every newborn should receive the hepatitis B vaccine as early as possible after birth, followed by completion of the recommended vaccination schedule.

Adults who have never been vaccinated, especially healthcare workers, family members of infected individuals, dialysis patients and people with chronic medical conditions, should also consider immunisation after consulting their physician.

Equally important is screening. Individuals with diabetes, obesity, chronic liver disease, a family history of hepatitis B or liver cancer, those who have received blood transfusions before improved screening practices were introduced, or anyone with unexplained abnormal liver function tests should undergo hepatitis B and C testing. Pregnant women should also be routinely screened to reduce the risk of mother-to-child transmission.

Hyderabad is witnessing an increase in non-alcoholic fatty liver disease due to sedentary lifestyles, unhealthy dietary habits and rising obesity. Fatty liver can coexist with viral hepatitis, accelerating liver damage if left untreated. Maintaining a healthy weight, exercising regularly, limiting alcohol consumption and controlling diabetes and cholesterol are essential for preserving liver health.

Public awareness is equally vital. Misconceptions surrounding hepatitis often discourage people from seeking testing or treatment. Viral hepatitis is a medical condition—not a social stigma. Education, open conversations and community-based screening programmes can help identify infected individuals earlier and connect them with life-saving care.

Healthcare institutions across Hyderabad are now equipped with advanced diagnostic tools, liver elastography, therapeutic endoscopy, antiviral therapies and multidisciplinary liver care services. These advances have transformed outcomes for patients who receive timely treatment. However, technology alone cannot eliminate hepatitis. Awareness, vaccination, screening and early medical consultation remain the foundation of prevention.

The World Health Organization estimates that 287 million people were living with chronic hepatitis B or C in 2024, while 1.3 million people died from hepatitis-related liver disease and liver cancer. The organisation continues to call for expanded access to testing, vaccination and treatment to achieve the global goal of eliminating viral hepatitis as a public health threat by 2030.

On this World Hepatitis Day, every individual has a role to play. Get tested if you are at risk. Ensure your children receive hepatitis B vaccination. Do not ignore persistent liver-related symptoms. Support family members and friends who are undergoing treatment instead of allowing stigma to prevail.

By breaking down barriers to awareness, testing and treatment, Hyderabad can take meaningful steps toward a future where viral hepatitis no longer threatens lives. Protecting the liver today is an investment in a healthier tomorrow.

For more details: Munsif daily.com